Jim Cramer Says These Stocks ‘Nothing There’
June 10, 2024
Kura Oncology, Inc. (NASDAQ:KURA) on Wednesday announced $50 million financing tied to advancing its menin-inhibition strategy. Launches Caspian Therapeutics With $50 Million Financing Kura said it is launching Caspian Therapeutics alongside a $50 million financing led by BVF Partners, with participation from the T1D Fund, Invus, Montanova, Eli Lilly and Co. (NYSE:LLY), Kura Oncology, members […]
Vandana Singh | September 9, 2026
Ripple CEO Brad Garlinghouse on Thursday said making America the crypto capital of the world is “within reach” when he responded to CFTC Chairman Mike Selig’s post about the Aug.19 White House crypto meeting. CFTC Chairman Selig had thanked President Donald Trump for hosting crypto industry leaders at the White House last month, saying the […]
Parshwa Turakhiya | September 4, 2026
Bloomberg ETF analyst Eric Balchunas on Tuesday argued that spot Bitcoin (CRYPTO: BTC) ETFs have solved one of the asset’s biggest adoption problems by increasingly embedding the asset in traditional investment portfolios. Why ETF Inflows Matter BlackRock (NYSE:BLK) continues to dominate Bitcoin ETF inflows, with total assets across the products nearing $100 billion in August. […]
Khyathi Dalal | September 2, 2026
Dollar General Corp (NYSE:DG) on Thursday reported better-than-expected second-quarter financial results and raised its FY26 guidance above estimates. The discount retailer reported net sales of $11.29 billion, up 5.2% year over year. Revenue beat the consensus estimate of $11.197 billion. Earnings rose 33% to $2.48 per share, beating the Street estimate of $2.01. The result […]
Avi Kapoor | August 28, 2026
Shares of Moderna Inc. (NASDAQ:MRNA) are trading slightly lower Wednesday morning, taking a brief pause after surging more than 150% following landmark clinical trial updates for its oncology pipeline. The modest retreat reflects routine profit-taking and consolidation as investors digest the recent momentum. Moderna stock is among today’s weakest performers. Why is MRNA stock falling? […]
Henry Khederian | August 26, 2026
June 10, 2024
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |